Fluoresceine-Oxybuprocaine SDU Faure, Augentropfen

Recall | Medicines | 12/12/2023

The marketing authorisation holder informed its customers on December 12, 2023, that the mentioned batches could be potentially non-sterile. The affected batches are being recalled as a precautionary measure. The medicinal product is authorised in Switzerland and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.

Name of the medicinal product Fluoresceine-Oxybuprocaine SDU Faure, Augentropfen
Marketing authorisation number(s) 54756 (CH)
CIP code 3865551
Marketing authorisation holder OmniVision AG Schweiz
Distributor WABOSAN Arzneimittelvertriebs GmbH
Batch number(s) Batch, Expiry Date,
1S57, 01/2025
7S81, 06/2025
Classification of the recall1
Depth of recall Pharmacies
BASG reference number INS-640.001-4568

Further inquiry note